scholarly journals Effect of the Fermentation Broth of the Mixture of Pueraria lobata, Lonicera japonica, and Crataegus pinnatifida by Lactobacillus rhamnosus 217-1 on Liver Health and Intestinal Flora in Mice With Alcoholic Liver Disease Induced by Liquor

2021 ◽  
Vol 12 ◽  
Author(s):  
Ting Wang ◽  
Zhe Wang ◽  
Zhipeng Yang ◽  
Xin Cui ◽  
Liang Yan ◽  
...  

In this work, we discovered a new fermentation broth that can prevent and regulate alcoholic liver disease (ALD) and intestinal flora, which fermented the mixture of Pueraria lobata, Lonicera japonica, and Crataegus pinnatifida by Lactobacillus rhamnosus 217-1. The contents of polyphenols, puerarin, total isoflavones, and amino acids were significantly increased. Animal experiments showed that the fermentation broth could improve the liver indexes of ALD mice model, increase the activity of superoxide dismutase and glutathione in liver tissue, and reduce the level of malondialdehyde (MDA). Furthermore, the fermentation broth can reduce the levels of serum lipopolysaccharide (LPS), inflammatory factors interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). Importantly, intestinal flora analysis showed that the fermentation broth could increase the abundance of Lactobacillales and reduce the production of Gram-negative bacteria, thereby reducing the abnormal increase in bacterial diversity caused by alcohol. In conclusion, we may have discovered a new functional food raw material with great application potential. The above findings indicate that the fermentation broth can actively regulate the intestinal flora and improve liver inflammation. The underlying mechanism might be that the fermentation broth could enhance intestinal permeability and reduce the inflammatory signals and LPS transmitted through the gut-liver axis, thereby reducing the oxidative stress and inflammation of the liver caused by alcohol.

PLoS ONE ◽  
2015 ◽  
Vol 10 (2) ◽  
pp. e0117451 ◽  
Author(s):  
Meegun Hong ◽  
Seung Woo Kim ◽  
Sang Hak Han ◽  
Dong Joon Kim ◽  
Ki Tae Suk ◽  
...  

Medicina ◽  
2019 ◽  
Vol 55 (8) ◽  
pp. 459 ◽  
Author(s):  
Aleksejs Derovs ◽  
Sniedze Laivacuma ◽  
Angelika Krumina

The human microbiota is a variety of different microorganisms. The composition of microbiota varies from host to host, and it changes during the lifetime. It is known that microbiome may be changed because of a diet, bacteriophages and different processes for example, such as inflammation. Like all other areas of medicine, there is a continuous growth in the area of microbiology. Different microbes can reside in all sites of a human body, even in locations that were previously considered as sterile; for example, liver, pancreas, brain and adipose tissue. Presently one of the etiological factors for liver disease is considered to be pro-inflammatory changes in a host’s organism. There are lot of supporting data about intestinal dysbiosis and increased intestinal permeability and its effect on development of liver disease pointing to the gut–liver axis. The gut–liver axis affects pathogenesis of many liver diseases, such as chronic hepatitis B, chronic hepatitis C, alcoholic liver disease, non-alcoholic liver disease, non-alcoholic steatohepatitis, liver cirrhosis and hepatocellular carcinoma. Gut microbiota has been implicated in the regulation of brain health, emphasizing the gut–brain axis. Also, experiments with mice showed that microorganisms have significant effects on the blood–brain barrier integrity. Microbiota can modulate a variety of mechanisms through the gut–liver axis and gut–brain axis. Normal intestinal flora impacts the health of a host in many positive ways, but there is now significant evidence that intestinal microbiota, especially altered, have the ability to impact the pathologies of many diseases through different inflammatory mechanisms. At this point, many of the pathophysiological reactions in case of microbial disbyosis are still unclear.


2020 ◽  
Vol 69 (8) ◽  
pp. 789-800
Author(s):  
Liang-yun Li ◽  
Chen-chen Yang ◽  
Su-wen Li ◽  
Yu-min Liu ◽  
Hao-dong Li ◽  
...  

Phytomedicine ◽  
2019 ◽  
Vol 58 ◽  
pp. 152824 ◽  
Author(s):  
Ruibing Feng ◽  
Jie-Hua Chen ◽  
Cong-Hui Liu ◽  
Fang-Bo Xia ◽  
Zeyu Xiao ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-8
Author(s):  
Zelin Gu ◽  
Yanlong Liu ◽  
Shumeng Hu ◽  
Ying You ◽  
Wancong Li ◽  
...  

Many animal experiments and clinical trials showed that probiotics are effective for the treatment of alcoholic liver disease. Alcohol disrupts the composition of intestinal flora; probiotics modulate the gut microbiota and reverse alcohol-associated intestinal barrier dysfunction by decreasing intestinal mucosal permeability and preventing intestinal bacteria from translocating. Probiotics enhance immune responses and reduce the levels of alcohol-induced inflammatory cytokines and reactive oxygen species (ROS) production in the liver and intestine. Probiotics also increase fatty acid β-oxidation and reduce lipogenesis, combating alcohol-induced hepatic steatosis. In this review, we summarize the current knowledge regarding the mechanism of action of probiotics for reducing the effects of alcoholic liver disease.


2021 ◽  
Vol 160 (6) ◽  
pp. S-16
Author(s):  
Fengyuan Li ◽  
Zelin Gu ◽  
Mengwei Jiang ◽  
Lihua Zhang ◽  
Wenke Feng ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document